The meta-analyses concerning the effects of SSRIs, SNRIs, and TCAs also failed to demonstrate any significant effect of the treatment on IFN-γ levels in patients with MDD (p > 0.05) [24,25,26]. The gene discussed is IFNG; the disease is major depressive disorder.